The immunogen is a synthetic peptide directed towards the middle region of human DLD
Alternative Synonym:
E3, LAD, DLDD, DLDH, GCSL, PHE3, OGDC-E3
DLD is the L protein of the mitochondrial glycine cleavage system. The L protein, also named dihydrolipoamide dehydrogenase, is also a component of the pyruvate dehydrogenase complex, the alpha-ketoglutarate dehydrogenase complex, and the branched-chain alpha-keto acide dehydrogenase complex. Mutations in this gene have been identified in patients with E3-deficient maple syrup urine disease and lipoamide dehydrogenase deficiency.This gene encodes the L protein of the mitochondrial glycine cleavage system. The L protein, also named dihydrolipoamide dehydrogenase, is also a component of the pyruvate dehydrogenase complex, the alpha-ketoglutarate dehydrogenase complex, and the branched-chain alpha-keto acide dehydrogenase complex. Mutations in this gene have been identified in patients with E3-deficient maple syrup urine disease and lipoamide dehydrogenase deficiency. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications.
WB Suggested Anti-DLD Antibody Titration: 0.2-1 ug/ml ELISA Titer: 1:62500 Positive Control: Jurkat cell lysateDLD is supported by BioGPS gene expression data to be expressed in Jurkat
DLD antibody - middle region (ARP58455_P050) validated by WB using Proximal kidney tubules purfied from cortex at 1:1000.
Host: Rabbit Target Name: NOP56 Sample Type: MCF7 Antibody Dilution: 1.0ug/mlDLD is supported by BioGPS gene expression data to be expressed in MCF7